Clinical Trials Browser

Phase 1 × Castration-resistant Prostate Cancer × enzalutamide × Clear all

NCT02207504 2022-01-06

Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Phase 1 Completed

Castration-resistant Prostate Cancer